Saltar al contenido
Merck

iRFP is a real time marker for transformation based assays in high content screening.

PloS one (2014-06-03)
Viola Paulus-Hock, Eric C Cheung, Patricia Roxburgh, Karen H Vousden, Andreas K Hock
RESUMEN

Anchorage independent growth is one of the hallmarks of oncogenic transformation. Here we show that infrared fluorescent protein (iRFP) based assays allow accurate and unbiased determination of colony formation and anchorage independent growth over time. This protocol is particularly compatible with high throughput systems, in contrast to traditional methods which are often labor-intensive, subjective to bias and do not allow further analysis using the same cells. Transformation in a single layer soft agar assay could be documented as early as 2 to 3 days in a 96 well format, which can be easily combined with standard transfection, infection and compound screening setups to allow for high throughput screening to identify therapeutic targets.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Reactivo de transfección GeneJuice®, Non-lipid based chemical transfection reagent optimized for maximum transfection efficiency, ease-of-use, and minimal cytotoxicity on a wide variety of mammalian cells.
Sigma-Aldrich
Actinomycin D, from Streptomyces sp., ~98% (HPLC)
Sigma-Aldrich
Actinomycin D, from Streptomyces sp., suitable for cell culture, ≥95%
Sigma-Aldrich
Actinomycin D, from Streptomyces sp., ≥95% (HPLC)
Sigma-Aldrich
Dulbecco′s Modified Eagle′s Media 2X, With 4,500 mg/L Glucose and L-Glutamine, without NaHCO3 or Sodium Pyruvate
Sigma-Aldrich
Nutlin-3, ≥98% (HPLC), powder